Skip to content

Effectiveness of Individualized Homoeopathy medicines in Autism Spectrum Disorder

Effectiveness of homoeopathic medicines as an primary mode of treatment or as an adjuvant therapy in treatment of autism spectrum disorder: a comparative non-randomized pilot study - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079619
Enrollment
20
Registered
2025-01-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F840- Autistic disorder

Interventions

Intervention1: Individualised homoeopathic medicines: Individualized homoeopathic treatment will be given for 6 months Intervention2: Individualised homoeopathic medicines along with conventional medi

Sponsors

Dr BHAGAT MIT BIMALKUMAR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants diagnosed with Autism Spectrum Disorder as per the DSM 5 Patient irrespective of race religion their socioeconomic status and their sex Children in the age group of 3 to 17 years Patient parents willing to give written informed consent and the patients willing to give verbal assent children aged between 7 to 11 years and or written assent children aged between 12 to 17 years If patients parents are willing but illiterate then they will be explained the importance of study and assent and consent will be written by physician and thumb impression will be taken Willingness and ability to comply with scheduled visits treatment plans and other study procedures Patient will have option to decide whether to take homoeopathic medicines along with the conventional treatment or to use stand alone homeopathic treatment Both the type of patient will be included in the study as two different arm of study

Exclusion criteria

Exclusion criteria: Participants diagnosed with any organic disorders. Participants with any other serious medical illness and multiple disabilities. Patient having any substance abuse.

Design outcomes

Primary

MeasureTime frame
Cast Childhood autism spectrum test Isaa Indian scale for assessment of autismTimepoint: At Baseline and 6 months

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr BHAGAT MIT BIMALKUMAR

National Institute of Homoeopathy

drshishirsinghmd@gmail.com7890321978

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026